CPAP Devices Can Be Used as Ventilators During Coronavirus Outbreak, FDA Guidance Says

Published in Member Communities on March 24, 2020

On March 22, it was announced that new temporary guidance from the FDA allows hospitals to re-purpose existing products such as CPAP devices as ventilators in an effort to meet major shortages in the United States during the coronavirus outbreak.

The guidance allows hospitals and manufacturers to make certain modifications to existing devices, or to production lines, to create more respiratory devices.

Ventilators normally used in other environments, such as ambulances, could be used for long-term care, the guidance says. It covers devices that aren't traditionally used for long-term care.

The guidance also would allow non-medical device companies, such as auto manufacturers, to start making ventilator parts.

The agency plans to use "enforcement discretion" for modifications to FDA-cleared devices. Traditionally manufacturers' modifications to ventilators would trigger an additional pre-market review, which could delay deployment.

The guidance means "America can make more ventilators during this crisis,” Health and Human Services Secretary Alex Azar said in a release.

The guidance also aims to create "maximum regulatory flexibility" while "still providing crucial FDA oversight," FDA Commissioner Stephen Hahn said in a release.

FDA is also encouraging manufacturers, including foreign ones, to contact the agency about emergency authorizations to distribute ventilators in the United States.

Original Updates:

 

From Our Experts

Cindi Petito on Bridging Gap Between CRT and Access thumbnail Cindi Petito on Bridging Gap Between CRT and Access Cindi Petito brings her extensive experience in CRT and home access industries to VGM & Associates to advocate for a holistic approach to in-home services. Cindi Petito on Bridging Gap Between CRT and Access thumbnail Cindi Petito on Bridging Gap Between CRT and Access Cindi Petito brings her extensive experience in CRT and home access industries to VGM & Associates to advocate for a holistic approach to in-home services. A Letter From the President: February 2025 thumbnail A Letter From the President: February 2025 Lindy Tentinger shares insights from VGM, including information on "VGM Playbook: Forecasting 2025," strategies for success, and the acquisition of SleepGlad. Supplier Enrollment Update and Continued Medical Need Reminder thumbnail Supplier Enrollment Update and Continued Medical Need Reminder Ronda Buhrmester, Sr. Director of Payer Relations and Reimbursement, shares updates on supplier enrollment and a reminder of continued medical need. Optimize Business Efficiency: Strategic Planning for Medicare Advantage Plans thumbnail Optimize Business Efficiency: Strategic Planning for Medicare Advantage Plans A proactive, informed, and strategic approach to Medicare Advantage Plans (MAPs) can lead to more efficient business operations, better resource allocation, and enhanced financial performance. The Intersection of Healthcare Leadership Insights and the DME Industry thumbnail The Intersection of Healthcare Leadership Insights and the DME Industry The insights from the J.P. Morgan Healthcare Conference 2025 highlight the dynamic nature of the healthcare industry and its impact on the DME sector. VGM & Associates Releases First Playbook for 2025 thumbnail VGM & Associates Releases First Playbook for 2025 “VGM Playbook: Forecasting 2025” offers a comprehensive roadmap for addressing the challenges and opportunities in the coming year. VGM & Associates Announces Retirement of Jim Greatorex thumbnail VGM & Associates Announces Retirement of Jim Greatorex Jim Greatorex of VGM Live at Home, a division of VGM & Associates, has announced his retirement as vice president, beginning in early 2025.